Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,973
datasets available to search
ShareScore release 0.9.0
Dataset results
1,973 results for “T cell receptor”
A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity
ClinicalTrials.gov study NCT03954106. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors
ClinicalTrials.gov study NCT01736917. IPD Sharing: NO. Countries: 1. Publications: 1.
CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
ClinicalTrials.gov study NCT03448393. IPD Sharing: YES. Countries: 1. Publications: 4.
A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B
ClinicalTrials.gov study NCT03277729. IPD Sharing: NO. Countries: 1. Publications: 1.
Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists
ClinicalTrials.gov study NCT07325435. IPD Sharing: NO. Countries: 1. Publications: 11.
CAR T Cell Receptor Immunotherapy for Patients With B-cell Lymphoma
ClinicalTrials.gov study NCT00924326. IPD Sharing: NO. Countries: 1. Publications: 10.
Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors
ClinicalTrials.gov study NCT03250832. IPD Sharing: NO. Countries: 2. Publications: 1.
A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03548207. IPD Sharing: Not stated. Countries: 2. Publications: 11.
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients
ClinicalTrials.gov study NCT03745326. IPD Sharing: YES. Countries: 1. Publications: 3.
A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lun
ClinicalTrials.gov study NCT05388669. IPD Sharing: YES. Countries: 20. Publications: 1.
A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L
ClinicalTrials.gov study NCT02864251. IPD Sharing: Not stated. Countries: 10. Publications: 1.
T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers
ClinicalTrials.gov study NCT02280811. IPD Sharing: NO. Countries: 1. Publications: 3.
A Study of Tarceva (Erlotinib) as First Line Therapy in Participants With Non-Small Cell Lung Cancer Harbouring Epidermal Growth Factor Receptor (EGFR) Mutations
ClinicalTrials.gov study NCT01310036. IPD Sharing: Not stated. Countries: 4. Publications: 1.
T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas
ClinicalTrials.gov study NCT03049449. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of Osimertinib With or Without Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer (FLAURA2)
ClinicalTrials.gov study NCT04035486. IPD Sharing: YES. Countries: 21. Publications: 7.
T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive
ClinicalTrials.gov study NCT02153905. IPD Sharing: NO. Countries: 1. Publications: 3.
Study to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) Patients
ClinicalTrials.gov study NCT01526928. IPD Sharing: Not stated. Countries: 4. Publications: 2.
A Study of Tivozanib (AV-951), an Oral VEGF Receptor Tyrosine Kinase Inhibitor, in the Treatment of Renal Cell Carcinoma
ClinicalTrials.gov study NCT00502307. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Antigen-Independent, Autonomous B-cell Receptor Signalling in Diffuse Large B-cell Lymphoma
Open the record for dataset details and reuse information.
Data from: Gating-spring stiffness increases outer-hair-cell bundle stiffness, damping, and receptor current
Open the record for dataset details and reuse information.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.